Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinyuan Xiao

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Medicine|February 13, 2026
Prognostic nomogram for cancer-specific survival in adenosquamous carcinoma of lung patients treated with chemotherapy: A SEER-based retrospective cohort studyJinyuan Xiao, Jiarun Fan, Maoping Wang, et al.
Journal of Cosmetic Dermatology|July 10, 2025
Integrated Genomic and GEO Data Analysis Reveals Therapeutic Targets for RosaceaXinrui Deng, Sui He, Huiyu Long, et al.
Computational and Structural Biotechnology Journal|July 21, 2022
Pan-cancer analyses of synonymous mutations based on tissue-specific codon optimalityXia Ran, Jinyuan Xiao, Fang Cheng, et al.
Therapeutic Advances in Medical Oncology|January 11, 2021
Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinomaXia Ran, Jinyuan Xiao, Yi Zhang, et al.
Frontiers in Oncology|October 16, 2024
Case report: Germline <i>CHEK2</i> mutation is associated with a giant cell glioblastomaYongfeng Bi, Dong Wan, Si Chen, et al.
Frontiers in Oncology|July 14, 2022
A Novel Computational Framework for Predicting the Survival of Cancer Patients With PD-1/PD-L1 Checkpoint Blockade TherapyXiaofan Su, Haoxuan Jin, Ning Du, et al.
Journal for Immunotherapy of Cancer|June 1, 2023
Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumorsYuxiang Ma, Jinhui Xue, Yuanyuan Zhao, et al.
Pharmacological Research|October 28, 2023
Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancerShifen Zhang, Na Li, Feifei Wang, et al.
Clinical and Translational Medicine|November 27, 2023
Multi-omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinomaHaitao Huang, Na Li, Yingkuan Liang, et al.
Annals of Hematology|October 10, 2025
A comprehensive analysis of B symptoms reveals prognosis and heterogeneity across different sites of diffuse large B-cell lymphomaChaoling Wu, Yongjun Zhang, Fan Yang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Medicine|February 13, 2026
Prognostic nomogram for cancer-specific survival in adenosquamous carcinoma of lung patients treated with chemotherapy: A SEER-based retrospective cohort studyJinyuan Xiao, Jiarun Fan, Maoping Wang, et al.
Journal of Cosmetic Dermatology|July 10, 2025
Integrated Genomic and GEO Data Analysis Reveals Therapeutic Targets for RosaceaXinrui Deng, Sui He, Huiyu Long, et al.
Computational and Structural Biotechnology Journal|July 21, 2022
Pan-cancer analyses of synonymous mutations based on tissue-specific codon optimalityXia Ran, Jinyuan Xiao, Fang Cheng, et al.
Therapeutic Advances in Medical Oncology|January 11, 2021
Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinomaXia Ran, Jinyuan Xiao, Yi Zhang, et al.
Frontiers in Oncology|October 16, 2024
Case report: Germline <i>CHEK2</i> mutation is associated with a giant cell glioblastomaYongfeng Bi, Dong Wan, Si Chen, et al.
Frontiers in Oncology|July 14, 2022
A Novel Computational Framework for Predicting the Survival of Cancer Patients With PD-1/PD-L1 Checkpoint Blockade TherapyXiaofan Su, Haoxuan Jin, Ning Du, et al.
Journal for Immunotherapy of Cancer|June 1, 2023
Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumorsYuxiang Ma, Jinhui Xue, Yuanyuan Zhao, et al.
Pharmacological Research|October 28, 2023
Characterization of the tumor microenvironment and identification of spatially predictive biomarkers associated with beneficial neoadjuvant chemoradiotherapy in locally advanced rectal cancerShifen Zhang, Na Li, Feifei Wang, et al.
Clinical and Translational Medicine|November 27, 2023
Multi-omics analyses reveal spatial heterogeneity in primary and metastatic oesophageal squamous cell carcinomaHaitao Huang, Na Li, Yingkuan Liang, et al.
Annals of Hematology|October 10, 2025
A comprehensive analysis of B symptoms reveals prognosis and heterogeneity across different sites of diffuse large B-cell lymphomaChaoling Wu, Yongjun Zhang, Fan Yang, et al.
Pageof 2